The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission
|
|---|---|
| Published in |
Frontiers in immunology, January 2022
|
| DOI | 10.3389/fimmu.2021.731435 |
| Pubmed ID | |
| Authors |
Guan-hua Hu, Yi-fei Cheng, Ying-xi Zuo, Ying-jun Chang, Pan Suo, Jun Wu, Yue-ping Jia, Ai-dong Lu, Ying-chun Li, Yu Wang, Shun-chang Jiao, Long-ji Zhang, Xiang-yu Zhao, Chen-hua Yan, Lan-ping Xu, Xiao-hui Zhang, Kai-yan Liu, Yu Wang, Le-ping Zhang, Xiao-jun Huang |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | 11% |
| United States | 1 | 11% |
| Saudi Arabia | 1 | 11% |
| Unknown | 6 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 56% |
| Practitioners (doctors, other healthcare professionals) | 2 | 22% |
| Scientists | 1 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 24 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 4 | 17% |
| Student > Doctoral Student | 2 | 8% |
| Student > Master | 2 | 8% |
| Student > Postgraduate | 2 | 8% |
| Researcher | 2 | 8% |
| Other | 4 | 17% |
| Unknown | 8 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 33% |
| Unspecified | 4 | 17% |
| Nursing and Health Professions | 2 | 8% |
| Social Sciences | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 8 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2022.
All research outputs
#7,422,171
of 26,456,908 outputs
Outputs from Frontiers in immunology
#8,307
of 33,275 outputs
Outputs of similar age
#157,601
of 532,179 outputs
Outputs of similar age from Frontiers in immunology
#377
of 1,552 outputs
Altmetric has tracked 26,456,908 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 33,275 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 532,179 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 1,552 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.